Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 9, 1997, Pages 1707-1715

  Whitman, Stewart C ^b   Miller, David B ^b   Wolfe, Bernard M ^b   Regele, Robert A ^b   Huff, Murray W ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

Foam cells; Remnants oxidation; Type III HLP; VLDL

Indexed keywords

CHOLESTEROL ESTER; COPPER SULFATE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; LIPID OXIDATION; LIPID TRANSPORT; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030823624     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.9.1707     Document Type: Article

References (18)

1. Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, Glagov S, Wissler RW. Arterial foam cells with distinctive immunomorphic and histochemical features of macrophages. Am J Pathol. 1980;100:57-80.
2. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
3. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sei USA. 1980;77:2214-2218.
4. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sei USA. 1981;78: 6499-6503.
5. Hoff HF, O'Neil JA. Oxidation of LDL: role in atherogenesis. Klin Wochenschr. 1991;69:1032-1038.
6. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
7. Huff MW, Evans AJ, Sawyez CG, Wolfe BM, Nestel PJ. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins: a comparison of VLDL from subjects with types III, IV, and V hyperlipoproteinemia. Arterioscler Thromb. 1991;11:221-233.
8. Evans AJ, Sawyez CG, Wolfe BM, Connelly PW, Maguire GF, Huff MW. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by .very low density subfractions occurs by different mechanisms. J Lipid Res. 1993;34:703-717.
9. Gianturco SH, Bradley WA, Gotto AM, Morrisett JD, Peavy DL. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis in mouse peritoneal macrophages. J Clin Invest. 1982;70:168-178.
10. Lindqvist P, Ostlund-Lindqvist A, Witztum JL, Steinberg D, Little JA. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J Biol Chem. 1983;258: 9086-9092.
11. Sacks FM, Breslow JL. Very low density lipoproteins stimulate cholesterol ester formation in U937 macrophages: heterogeneity and biologic variation among normal humans. Arteriosclerosis. 1987; 7:35-46.
12. Bates SR, Coughlin BA, Mazzone T, Borensztajn J, Getz GS. Apoprotein E mediates the interaction of beta-VLDL with macrophages. J Lipid Res. 1987;28:787-797.
13. Ishibashi S, Yamaha N, Shimano H, Mori N, Mokuno H, Gotohda T, Kawakami M, Murase T, Takaku F. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J Biol Chem. 1990;265:3040-3047.
14. Granot E, Eisenberg S. ApoE-3-specific metabolism of human plasma very low density lipoproteins in cultured J-774 macrophages. J Lipid Res. 1990;31:2133-2139.
15. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer RJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272: 1666-1671.
16. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
17. Innerarity TL, Arnold KH, Weisgraber KH, Mahley RW. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages. Arteriosclerosis. 1986;6:114-122.
18. Fainaru M, Mahley RW, Hamilton RL, Innerarity TL. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res. 1982;23:702-714.